(Q35340278)

English

Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli (English)

1 reference

Europe PubMed Central

7 August 2017

Gram-negative bacteria

0 references

1 reference

based on heuristic

inferred from title

author name string

DeMaria A Jr

1

1 reference

Europe PubMed Central

7 August 2017

Treadwell TL

2

1 reference

Europe PubMed Central

7 August 2017

Saunders CA

3

1 reference

Europe PubMed Central

7 August 2017

Porat R

4

1 reference

Europe PubMed Central

7 August 2017

McCabe WR

5

1 reference

Europe PubMed Central

7 August 2017

language of work or name

0 references

publication date

1 August 1989

1 reference

Europe PubMed Central

7 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

7 August 2017

33

1 reference

Europe PubMed Central

7 August 2017

8

1 reference

Europe PubMed Central

7 August 2017

1137-1143

1 reference

Europe PubMed Central

7 August 2017

The gram-negative bacillary pneumonias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

12 July 2018

Cross-allergenicity and immunogenicity of aztreonam.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

12 July 2018

Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

12 July 2018

Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

12 July 2018

Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

12 July 2018

Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

12 July 2018

Review of the clinical pharmacology of the monobactam antibiotic aztreonam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

12 July 2018

Safety profile of aztreonam in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

12 July 2018

Serum Dilution Test for Bactericidal Activity. I. Selection of a Physiologic Diluent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

12 July 2018

Antibacterial activity of a monocyclic beta-lactam SQ 26,776.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

26 September 2018

Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172614

26 September 2018

Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2679368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2679368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of serious gram-negative infections with aztreonam

1 reference

https://pubmed.ncbi.nlm.nih.gov/2679368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2679368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aztreonam: worldwide overview of the treatment of patients with gram-negative infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2679368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2679368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2679368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.33.8.1137

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35340278&oldid=1582424201"